Breast Cancer And Immunology

Breast cancer and immunology intersect in crucial ways, influencing both the development of the disease and its treatment strategies. The immune system plays a pivotal role in recognizing and eliminating cancer cells, but breast cancer can evade detection by altering immune responses or creating an immunosuppressive environment. Understanding these mechanisms is key to developing immunotherapies that harness the body's immune defenses against cancer. Immunotherapy, such as immune checkpoint inhibitors and CAR T-cell therapy, is revolutionizing breast cancer treatment by enhancing immune responses specifically targeting cancer cells. Additionally, studies explore the role of tumor-infiltrating lymphocytes (TILs) and immune biomarkers in predicting treatment response and prognosis. Advancements in immunology continue to pave the way for personalized medicine approaches, offering new hope for improving outcomes and quality of life for breast cancer patients.

    Related Conference of Breast Cancer And Immunology

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Breast Cancer And Immunology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in